한글목차

헬스케어 유통 시장 규모는 2025년 1조 8,100억 달러에서 2026년부터 2034년까지 CAGR 7.72%로 성장하여 2034년에는 3조 5,300억 달러에 달할 것으로 예측됩니다.

헬스케어 유통 시장은 의료 분야의 효율적이고 신뢰할 수 있는 공급망 솔루션에 대한 수요 증가를 배경으로 큰 폭의 성장이 예상됩니다. 세계 의료 환경의 변화 속에서 의료용품, 의약품, 의료기기의 적시 배송의 필요성이 매우 중요해지고 있습니다. E-Commerce와 디지털 플랫폼의 등장은 전통적인 유통 모델을 변화시키고, 의료 서비스 제공자가 조달 프로세스를 효율화하고 재고 관리를 강화할 수 있도록 하고 있습니다. 온도 제어 운송 및 실시간 추적 시스템과 같은 물류 분야의 혁신은 헬스케어 유통의 효율성과 신뢰성을 더욱 향상시켜 중요한 제품이 목적지까지 안전하고 제때에 도착할 수 있도록 보장합니다.

또한, 환자 중심의 케어에 대한 관심이 높아지면서 헬스케어 유통 시장에도 영향을 미치고 있습니다. 의료 서비스 제공자가 환자 치료 결과를 개선하기 위해 의료용품 및 장비의 적시 배송에 대한 수요가 증가하고 있습니다. 이러한 추세는 특히 급성기 의료 현장에서 두드러지게 나타나고 있으며, 필수 제품에 대한 적시 접근이 환자 치료에 큰 영향을 미칩니다. 또한, 원격의료 및 재택 의료 서비스의 보급은 원격지 환자 진료에 대응하는 유통 솔루션의 필요성을 증가시켜 시장의 잠재적 가능성을 더욱 확대시키고 있습니다.

또한, 규제 준수와 안전 기준은 헬스케어 유통 시장에서 점점 더 중요해지고 있습니다. 의료기관이 의료 제품 취급 및 운송에 대한 엄격한 규제에 직면한 가운데, 유통업체는 컴플라이언스 준수를 보장하기 위해 품질 보증 및 리스크 관리 방법에 대한 투자가 요구됩니다. 블록체인과 인공지능과 같은 첨단 기술의 통합으로 공급망의 투명성과 추적성이 향상되고, 제품 품질과 안전에 대한 감시가 강화되고 있습니다. 요약하면, 헬스케어 유통 시장은 기술 혁신, 환자 중심 솔루션에 대한 집중, 의료 제품의 안전하고 효율적인 배송을 보장하기 위한 노력으로 인해 견조한 성장이 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 헬스케어 유통 시장 : 유형별

제5장 세계의 헬스케어 유통 시장 : 최종사용별

제6장 세계의 헬스케어 유통 시장 : 지역별

제7장 경쟁 구도

제8장 기업 개요

영문목차

The Healthcare Distribution Market size is expected to reach USD 3.53 Trillion in 2034 from USD 1.81 Trillion (2025) growing at a CAGR of 7.72% during 2026-2034.

The healthcare distribution market is poised for significant growth, driven by the increasing demand for efficient and reliable supply chain solutions in the healthcare sector. As the global healthcare landscape evolves, the need for timely delivery of medical supplies, pharmaceuticals, and equipment has become paramount. The rise of e-commerce and digital platforms is transforming traditional distribution models, enabling healthcare providers to streamline their procurement processes and enhance inventory management. Innovations in logistics, such as temperature-controlled transportation and real-time tracking systems, are further improving the efficiency and reliability of healthcare distribution, ensuring that critical products reach their destinations safely and on time.

Moreover, the growing emphasis on patient-centered care is influencing the healthcare distribution market. As healthcare providers seek to improve patient outcomes, the demand for just-in-time delivery of medical supplies and equipment is increasing. This trend is particularly relevant in acute care settings, where timely access to essential products can significantly impact patient care. Additionally, the rise of telehealth and home healthcare services is driving the need for distribution solutions that cater to remote patient care, further expanding the market's potential.

Furthermore, regulatory compliance and safety standards are becoming increasingly important in the healthcare distribution market. As healthcare organizations face stringent regulations regarding the handling and transportation of medical products, distributors must invest in quality assurance and risk management practices to ensure compliance. The integration of advanced technologies, such as blockchain and artificial intelligence, is enhancing transparency and traceability in the supply chain, allowing for better monitoring of product quality and safety. In summary, the healthcare distribution market is set for robust growth, characterized by technological advancements, a focus on patient-centered solutions, and a commitment to ensuring the safe and efficient delivery of healthcare products.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Pharmaceutical Product Distribution ServicesA (Otc Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs)
• Biopharmaceutical Product Distribution ServicesA (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other Products)
• Medical Device Distribution Services

By End-use

• Hospital Pharmacies
• Retail Pharmacies
• Others

COMPANIES PROFILED

• Alliance Healthcare, AmerisourceBergen Corporation, Anda, Inc, Cardinal Health, Inc, Celesio AG, CuraScript SD, Henry Schein, Inc, McKesson Corporation, Medline Industries, Inc, Morris Dickson Co, LLC, Owens Minor, Inc, Patterson Companies, Inc, Phoenix Group, Sinopharm Group, Suzuken Co, Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE DISTRIBUTION MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Pharmaceutical Product Distribution ServicesA (Otc Drugs/Vitamins, Generic Drugs, Brand-Name/Innovator Drugs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Biopharmaceutical Product Distribution ServicesA (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Blood And Blood Products, Other Products) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Medical Device Distribution Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE DISTRIBUTION MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE DISTRIBUTION MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End-use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End-use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End-use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End-use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End-use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE DISTRIBUTION INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Alliance Healthcare
  • 8.2.2 AmerisourceBergen Corporation
  • 8.2.3 AndaInc
  • 8.2.4 Cardinal HealthInc
  • 8.2.5 Celesio AG
  • 8.2.6 CuraScript SD
  • 8.2.7 Henry ScheinInc
  • 8.2.8 McKesson Corporation
  • 8.2.9 Medline IndustriesInc
  • 8.2.10 Morris & Dickson Co., LLC
  • 8.2.11 Owens & MinorInc
  • 8.2.12 Patterson CompaniesInc
  • 8.2.13 Phoenix Group
  • 8.2.14 Sinopharm Group
  • 8.2.15 Suzuken Co.Ltd